HemaSpot, a Novel Blood Storage Device for HIV-1 Drug Resistance Testing

被引：15
|
作者：
Brooks, K. [1 ]
DeLong, A. [2 ]
Balamane, M. [1 ]
Schreier, L. [1 ]
Orido, M. [3 ]
Chepkenja, M. [3 ]
Kemboi, E. [3 ]
D'Antuono, M. [1 ]
Chan, P. A. [1 ]
Emonyi, W. [3 ,4 ]
Diero, L. [3 ,4 ]
Coetzer, M. [1 ]
Kantor, R. [1 ]
机构：
[1] Brown Univ, Div Infect Dis, Alpert Med Sch, Providence, RI 02912 USA
[2] Brown Univ, Ctr Stat Sci, Sch Publ Hlth, Providence, RI 02912 USA
[3] Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya
[4] Moi Univ, Dept Med, Sch Med, Coll Hlth Sci, Eldoret, Kenya
来源：
JOURNAL OF CLINICAL MICROBIOLOGY | 2016年 / 54卷 / 01期
关键词：
ANTIRETROVIRAL THERAPY; VIRAL LOAD; SPOT SPECIMENS; SURVEILLANCE; SETTINGS;
D O I：
10.1128/JCM.02853-15
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
HemaSpot, a novel dried-blood storage filter device, was used for HIV-1 pol resistance testing in 30 fresh United States blood samples and 54 previously frozen Kenyan blood samples. Genotyping succeeded in 79% and 58% of samples, respectively, improved with shorter storage and higher viral load, and had good (86%) resistance mutation concordance to plasma.
引用
收藏
页码：223 / 225
页数：3
相关论文
共 50 条
  • [21] Feasibility of testing and detection of HIV-1 drug resistance in proviral DNA
    Clare L Booth
    Adele McCormick
    Ana Garcia-Diaz
    Malcolm Macartney
    Michael Youle
    Margaret Johnson
    Daniel Webster
    BMC Infectious Diseases, 14 (Suppl 4)
  • [22] Dried blood spots for HIV-1 Drug Resistance and Viral Load Testing: A Review of Current Knowledge and WHO Efforts for Global HIV Drug Resistance Surveillance
    Bertagnolio, Silvia
    Parkin, Neil T.
    Jordan, Michael
    Brooke, James
    Garcia-Lerma, J. Gerardo
    AIDS REVIEWS, 2010, 12 (04) : 195 - 208
  • [23] Stability of Dried Blood Spots for HIV-1 Drug Resistance Analysis
    Hearps, Anna C.
    Ryan, Claire E.
    Morris, Lisa M.
    Plate, Megan M.
    Greengrass, Vicki
    Crowe, Suzanne M.
    CURRENT HIV RESEARCH, 2010, 8 (02) : 134 - 140
  • [24] Antiretroviral drug resistance in HIV-1
    George J. Hanna
    Richard T. D’Aquila
    Current Infectious Disease Reports, 1999, 1 (3) : 289 - 297
  • [25] Mechanisms of HIV-1 drug resistance
    Larder, B
    AIDS, 2001, 15 : S27 - S34
  • [26] Understanding HIV-1 drug resistance
    Frenkel, LM
    Tobin, NH
    THERAPEUTIC DRUG MONITORING, 2004, 26 (02) : 116 - 121
  • [27] Transmission of HIV-1 drug resistance
    Tang, JW
    Pillay, D
    JOURNAL OF CLINICAL VIROLOGY, 2004, 30 (01) : 1 - 10
  • [28] Stability of HIV-1 Nucleic Acids in Dried Blood Spot Samples for HIV-1 Drug Resistance Genotyping
    Aitken, Susan C.
    Wallis, Carole L.
    Stevens, Wendy
    de Wit, Tobias Rinke
    Schuurman, Rob
    PLOS ONE, 2015, 10 (07):
  • [29] Plasma separation cards are suitable for HIV-1 genotypic drug resistance testing
    Reddy, H.
    Liao, Y. X.
    Hans, L.
    Noble, L.
    Scott, L.
    Stevens, W.
    Steegen, K.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24 : 24 - 25
  • [30] Introduction of TaqMan HIV-1 Assay Increased Unnecessary Drug Resistance Testing
    Gatanaga, Hiroyuki
    Oowa, Minoru
    Oka, Shinichi
    AIDS PATIENT CARE AND STDS, 2010, 24 (04) : 203 - 204
12345